TILS.L Regulatory News (TILS)

14 Jul 2006 17:38

ReGen Therapeutics PLC14 July 2006 ReGen Therapeutics Plc 14 July 2006 Statement regarding current year revenue ReGen Therapeutics Plc ("ReGen") is aware of recent market uncertainty inrelation to its expected revenues for the current financial year. ReGen confirms that Guildford Clinical Pharmacology Unit Limited ("GCPUL") isthe only company in the ReGen group which currently has revenues. The currentorder book is around £870,000, with ReGen being the largest single customer.Accordingly, based on the current order book, ReGen's expectation of externalrevenue from GCPUL for the current financial year is in the region of £550,000to £600,000. In addition, GCPUL continues in its discussions in relation to anumber of potential orders. Further information: Andrew MarshallGreycoat CommunicationsTel: 020 7960 6007Mobile: 07785 297111 This information is provided by RNS The company news service from the London Stock Exchange